Daveen Chopra - 26 Aug 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP, TMTT, Surgical & IHFM
Issuer ticker: EW
Reported as of: 26 Aug 2026
Net transaction value: -$2,894,440
SEC form: 4
Accepted by SEC: 26 Aug 2026, 18:36:41 UTC
Prior SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Daveen Chopra filed Form 4 for Edwards Lifesciences Corp (EW) on 26 Aug 2026.

Key facts

This page summarizes Daveen Chopra's Form 4 filing for Edwards Lifesciences Corp (EW).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Aug 2026, 18:36.

Change

Previous filing in this sequence was filed on 22 May 2026.
Current net transaction value: -$2,894,440.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001740963 Primary reporting owner

Chopra Daveen

Relationship: CVP, TMTT, Surgical & IHFM
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 26 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Options Exercise

Transaction value
Shares: +31,800
Change %: +72%
Price: $72.68^*
Shares after: 76,124
Date: 26 Aug 2026
Ownership: Direct

EW transaction

Common Stock

Sale

Transaction value: $105,893
Shares: -1,154
Change %: -1.5%
Price: $91.76
Shares after: 74,970
Date: 26 Aug 2026
Ownership: Direct
Footnotes: F1

EW transaction

Common Stock

Sale

Transaction value: $2,788,547
Shares: -30,646
Change %: -41%
Price: $90.99
Shares after: 44,324
Date: 26 Aug 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EW transaction Derivative

Employee Stock Option (Right to Acquire)

Options Exercise

Transaction value
Shares: -31,800
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 26 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,800
Exercise price: $72.68

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.